We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: ABBOTT LABS' KALETRA ADS OVERSTATE PRODUCT EFFICACY
Abbott Laboratories has been cited by the FDA for a pair of direct-to-consumer promotional pieces that exaggerate the benefits of its HIV drug, Kaletra, while omitting significant risk information.